PositiveID Corporation Partners With Diabetes Research Institute at the University of Miami and Schneider Children's Medical Center of Israel to Support Development of PositiveID's Diabetes Management Products
January 03, 2012 08:30 ET
|
PositiveID Corporation
Diabetes Research Institute is a Recognized World Leader in Cure-Focused Diabetes Research
Schneider Children's Medical Center of Israel is the Only Highly Specialized Care Hospital of...
PositiveID Corporation Announces 2011 Accomplishments and Discusses Outlook for 2012
December 12, 2011 08:30 ET
|
PositiveID Corporation
Company Receives FDA Clearance for Its iglucose System, Completes Easy Check Prototype and
Initial Testing, Completes Development of Glucose Sensor for GlucoChip, and Acquires
MicroFluidic...
PositiveID Corporation Appoints William J. Caragol, the Company's CEO, Chairman of Its Board of Directors
December 07, 2011 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Dec. 7, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB: PSID), a developer of medical technologies and molecular diagnostic systems, announced...
PositiveID Corporation Successfully Passes FCC Requirements to Sell Its iglucose System for Diabetes Management in the U.S.
November 28, 2011 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 28, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical...
U.S Food and Drug Administration Clears PositiveID's iglucose System for Diabetes Management
November 16, 2011 08:30 ET
|
PositiveID Corporation
iglucose is a First-of-its-Kind Wireless Communication System for Diabetes Management
PositiveID to Begin Commercialization Efforts in First Quarter 2012
DELRAY BEACH, Fla., Nov. 16, 2011 (GLOBE...
PositiveID Corporation Announces Third Quarter 2011 Highlights
November 15, 2011 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Nov. 15, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics...
Sanofi and the American Medical Directors Association Foundation Sponsor Study Using PositiveID Corporation's iglucose Mobile Health System for Diabetes Management
October 04, 2011 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Oct. 4, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical...
Diabetes Educators Confirm PositiveID Corporation's iglucose Would Improve Patient Outcomes
September 27, 2011 08:30 ET
|
PositiveID Corporation
Eighty-Three Percent of Diabetes Educators Polled at the American Association of Diabetes Educators Conference Believe iglucose Would Improve Patient Outcomes
PositiveID Submitted Its 510(k)...
PositiveID Corporation's iglucose Mobile Health System for Diabetes Management Selected to be Featured at Rogers Wireless Technology Showcase 2011
September 08, 2011 08:00 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Sept. 8, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical...
PositiveID Corporation Files Patent for Glucose-Sensing System to be Used in Its GlucoChip Microchip for Patients With Diabetes
August 24, 2011 16:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., Aug. 24, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...